"hyderabad-pharma-company"

Hyderabad-based Aurobindo says buyback will reward shareholders, boost returns, improve earnings per share, without changing control or affecting management structure

Should the offer be accepted, the company will hold a 35.75 per cent stake in the South Africa firm, valued at R4 billion (USD 226 million), the company stated in a regulatory filing

Aurobindo Pharma will manufacture and supply these injectable HIV treatment across 133 countries, including several low and middle-income markets

The drug-maker is recalling India-produced Metoprolol Succinate extended-release tablets in 100 count and 500 count bottles in US

The company has also offered voluntary retirement to employees aged 50-55 within its research and development division; multiple high-salaried employees across various departments have already been asked to resign, reports stated